MarketCapTrends
NVCR

NovoCure Ltd. (NVCR)

NASDAQ · Healthcare

NovoCure Ltd. annual/quarterly cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • NovoCure Ltd. cash on hand for the quarter ending December 31, 2025 were 93.5M, a 42.88% decrease year-over-year.
  • NovoCure Ltd. cash on hand for 2025 were 93.5M, a 42.88% decrease from 2024.
  • NovoCure Ltd. cash on hand for 2024 were 163.8M, a 32.00% decrease from 2023.
  • NovoCure Ltd. cash on hand for 2023 were 240.8M, a 108.82% increase from 2022.
  • NovoCure Ltd. cash on hand for 2022 were 115.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
NovoCure Ltd. Annual Cash on Hand (Millions of US $)
2025$94
2024$164
2023$241
2022$115
2021$209
2020$235
2019$177
2018$141
2017$79
2016$100
2015$119
2014$58
NovoCure Ltd. Quarterly Cash on Hand (Millions of US $)
2025-12-31$94
2024-12-31$164
2023-12-31$241
2022-12-31$115
2021-12-31$209
2020-12-31$235
2019-12-31$177
2018-12-31$141
2017-12-31$79
2016-12-31$100
2015-12-31$119
2014-12-31$58

NovoCure Ltd. Cash on Hand — FAQ

NovoCure Ltd. (NVCR) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see NVCR's cash on hand history?

The chart and table above show NovoCure Ltd.'s cash on hand by year and by quarter, including the growth rate.